Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, P. R. China.
Department of Pathology, Third Affiliated Hospital of Harbin Medical University, Harbin, P. R. China.
Cancer Invest. 2022 Aug;40(7):604-620. doi: 10.1080/07357907.2022.2083148. Epub 2022 Jun 6.
The purposes of the present study were to elucidate the risk and prognostic effect of second primary cancers (SPCs) development, as well as the factors influencing the prognosis of OC patients with SPCs. A statistically significant increase in SPCs risk was observed among OC patients during 2004-2015. The independent factors were used to construct the SPCs-prediction nomogram and the OS-prediction nomogram. Both nomogram were subjected to internal validation and performed well. OC patients with SPCs have a better prognosis than patients without SPCs. Propensity score matching (PSM) was applied to reduce confounding.
本研究旨在阐明第二原发癌(SPC)发展的风险和预后影响,以及影响 OC 患者 SPC 预后的因素。在 2004 年至 2015 年期间,OC 患者 SPC 风险显著增加。利用独立因素构建了 SPC 预测列线图和 OS 预测列线图。这两个列线图都经过了内部验证,表现良好。患有 SPC 的 OC 患者的预后要好于没有 SPC 的患者。采用倾向评分匹配(PSM)来减少混杂因素。